Gender | Racial group All
Item
men and women of all races
boolean
C0079399 (UMLS CUI [1])
C0034510 (UMLS CUI [2,1])
C0444868 (UMLS CUI [2,2])
Age
Item
age 40-65 years
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Non-Insulin-Dependent
Item
diagnosis of type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Glycosylated hemoglobin A
Item
hemoglobin a1c ≥ 7%
boolean
C0019018 (UMLS CUI [1])
Hypoglycemic Agents
Item
eligible whether or not currently taking antihyperglycemic medications
boolean
C0020616 (UMLS CUI [1])
rosiglitazone | pioglitazone
Item
history of rosiglitazone or pioglitazone use in the previous 3 months
boolean
C0289313 (UMLS CUI [1])
C0071097 (UMLS CUI [2])
Peripheral Vascular Diseases | Heart failure
Item
known diagnosis of peripheral vascular disease or cardiac failure
boolean
C0085096 (UMLS CUI [1])
C0018801 (UMLS CUI [2])
Ischemic stroke | Myocardial Infarction | Percutaneous Coronary Intervention | Coronary Artery Bypass Surgery
Item
recent history (within past 6 months) of ischemic stroke, myocardial infarction, percutaneous coronary intervention, or coronary artery bypass surgery
boolean
C0948008 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C1532338 (UMLS CUI [3])
C0010055 (UMLS CUI [4])
Liver disease | Transaminases increased | Alanine aminotransferase measurement
Item
active liver disease or elevated serum transaminases (alt >2.5x upper limit of normal)
boolean
C0023895 (UMLS CUI [1])
C0438717 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
oral anticoagulants | Warfarin | Heparin | Heparin, Low-Molecular-Weight | clopidogrel | Immunosuppressive Agents
Item
current therapy with oral anticoagulants (warfarin, heparin, low molecular weight heparin), clopidogrel, or immunosuppressive agents
boolean
C0354604 (UMLS CUI [1])
C0043031 (UMLS CUI [2])
C0019134 (UMLS CUI [3])
C0019139 (UMLS CUI [4])
C0070166 (UMLS CUI [5])
C0021081 (UMLS CUI [6])
Pregnancy | Breast Feeding
Item
pregnancy or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Condition Compliance behavior Unable | Condition Interferes with Study Subject Participation Status | Condition At risk Significant Study Subject
Item
any other condition, in the opinion of the investigator, that renders the subject unable to complete the study, that interferes with optimal participation in the study, or that produces significant risk to the subject
boolean
C0348080 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
C0348080 (UMLS CUI [3,1])
C1444641 (UMLS CUI [3,2])
C0750502 (UMLS CUI [3,3])
C0681850 (UMLS CUI [3,4])